Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
Seres Therapeutics, Inc. (Seres), formerly Seres Health, Inc., is a microbiome therapeutics platform company that develops a novel class of biological drugs. It is involved in creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company's lead development candidate, SER-109, is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent Clostridium difficile infection in adults. Seres' second development candidate, SER-287, is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease. It utilizes its microbiome therapeutics platform to identify key alterations in the microbiome that are associated with or lead to specific diseases. Seres is headquartered in Cambridge, Massachusetts, the US.
Seres Therapeutics, Inc. Key Recent Developments
Aug 11, 2016: Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Progress Update
May 16, 2016: Seres Therapeutics Announces Appointment of Thomas J. DesRosier as Chief Legal Officer and Executive Vice President
May 16, 2016: Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Progress Update
Feb 25, 2016: Seres Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update
Jan 06, 2016: Seres Therapeutics Announces Appointment of Wael Hashad as Chief Commercial Officer
This comprehensive SWOT profile of Seres Therapeutics, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Seres Therapeutics, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Seres Therapeutics, Inc.-Key Information
Seres Therapeutics, Inc.-Overview
Seres Therapeutics, Inc.-Key Employees
Seres Therapeutics, Inc.-Key Employee Biographies
Seres Therapeutics, Inc.-Key Operational Heads
Seres Therapeutics, Inc.-Major Products and Services
Seres Therapeutics, Inc.-History
Seres Therapeutics, Inc.-Company Statement
Seres Therapeutics, Inc.-Locations And Subsidiaries
Seres Therapeutics, Inc.-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Seres Therapeutics, Inc.-Business Description
Seres Therapeutics, Inc.-Corporate Strategy
Seres Therapeutics, Inc.-SWOT Analysis
Seres Therapeutics, Inc.-Strengths
Seres Therapeutics, Inc.-Weaknesses
Seres Therapeutics, Inc.-Opportunities
Seres Therapeutics, Inc.-Threats
Seres Therapeutics, Inc.-Key Competitors
Section 3-Company Financial Performance Charts
Seres Therapeutics, Inc.-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Seres Therapeutics, Inc., Performance Chart
Seres Therapeutics, Inc., Ratio Charts
List of Tables
Seres Therapeutics, Inc., Key Information
Seres Therapeutics, Inc., Key Ratios
Seres Therapeutics, Inc., Share Data
Seres Therapeutics, Inc., Major Products and Services
Seres Therapeutics, Inc., History
Seres Therapeutics, Inc., Key Employees
Seres Therapeutics, Inc., Key Employee Biographies
Seres Therapeutics, Inc., Key Operational Heads
Seres Therapeutics, Inc., Other Locations
Seres Therapeutics, Inc., Subsidiaries
Seres Therapeutics, Inc., Key Manufacturing facilities
Seres Therapeutics, Inc., Key Competitors
Seres Therapeutics, Inc., SWOT Analysis
Seres Therapeutics, Inc., Ratios based on current share price
Seres Therapeutics, Inc., Annual Ratios
Seres Therapeutics, Inc., Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
Seres Therapeutics, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts